Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

191 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia.
Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Bytzer P, et al. Lancet. 1994 Apr 2;343(8901):811-6. doi: 10.1016/s0140-6736(94)92023-0. Lancet. 1994. PMID: 7980747 Clinical Trial.
Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making.
Hansen JM, Hallas J, Lauritsen JM, Bytzer P. Hansen JM, et al. Among authors: bytzer p. Scand J Gastroenterol. 1996 Feb;31(2):126-30. doi: 10.3109/00365529609031975. Scand J Gastroenterol. 1996. PMID: 8658033
[Survey of patients with upper gastrointestinal tract dyspepsia. A trial of H2 blocker therapy or endoscopy--a randomized trial of 2 management methods].
Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Bytzer P, et al. Ugeskr Laeger. 1995 Feb 13;157(7):893-7. Ugeskr Laeger. 1995. PMID: 7701651 Clinical Trial. Danish.
Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.
Lauritsen K, Rune SJ, Wulff HR, Olsen JH, Laursen LS, Havelund T, Astrup L, Bendtsen F, Linde J, Bytzer P, et al. Lauritsen K, et al. Among authors: bytzer p. Gut. 1988 Feb;29(2):249-53. doi: 10.1136/gut.29.2.249. Gut. 1988. PMID: 3278955 Free PMC article. Clinical Trial.
At two, four, and six weeks after entry ulcers healed in a larger percentage of patients treated with omeprazole (54, 81, and 86%) than of those treated with cimetidine (39, 73, and 78%) ('intention to treat' cohort; p less than 0.05 at two weeks). A higher proportion of p …
At two, four, and six weeks after entry ulcers healed in a larger percentage of patients treated with omeprazole (54, 81, and 86%) than of t …
Endoscopic follow-up study of gastric ulcer to detect malignancy: is it worthwhile?
Bytzer P. Bytzer P. Scand J Gastroenterol. 1991 Nov;26(11):1193-9. doi: 10.3109/00365529108998613. Scand J Gastroenterol. 1991. PMID: 1754856
[Drug therapy of non-ulcer dyspepsia].
Bytzer P. Bytzer P. Ugeskr Laeger. 1991 Aug 5;153(32):2212-6. Ugeskr Laeger. 1991. PMID: 1679263 Review. Danish.
[Over-the-counter availability of potent ulcer drugs. Study of changes in the drug use pattern and the pressure on diagnostic measures].
Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Bytzer P, et al. Ugeskr Laeger. 1991 May 13;153(20):1405-10. Ugeskr Laeger. 1991. PMID: 1674180 Danish.
[Health-economic aspects of newer anti-ulcer drugs].
Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Hansen JM, et al. Among authors: bytzer p. Ugeskr Laeger. 1992 Jun 8;154(24):1687-90. Ugeskr Laeger. 1992. PMID: 1352924 Review. Danish.
[Ulcer complications in the county of Funen during 1980-1990. Are there any changes in the frequency of hospitalization following the release of potent ulcer drugs for over-the-counter sale?].
Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Hansen JM, et al. Among authors: bytzer p. Ugeskr Laeger. 1991 May 13;153(20):1402-5. Ugeskr Laeger. 1991. PMID: 1674179 Danish.
[Is the clinical classification of dyspepsia patients worth the effort?].
Schaffalitzky de Muckadell OB, Bytzer P. Schaffalitzky de Muckadell OB, et al. Among authors: bytzer p. Ugeskr Laeger. 1994 Apr 11;156(15):2258-9. Ugeskr Laeger. 1994. PMID: 8016957 Danish. No abstract available.
191 results
Jump to page
Feedback